Entropy Technologies LP Has $663,000 Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Entropy Technologies LP grew its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI) by 84.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 16,280 shares of the real estate investment trust’s stock after purchasing an additional 7,448 shares during the quarter. Entropy Technologies LP’s holdings in Omega Healthcare Investors were worth $663,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of OHI. Daiwa Securities Group Inc. lifted its stake in Omega Healthcare Investors by 1,030.8% in the second quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust’s stock valued at $32,384,000 after buying an additional 861,907 shares in the last quarter. Marshall Wace LLP acquired a new position in shares of Omega Healthcare Investors in the second quarter valued at $20,962,000. BROOKFIELD Corp ON acquired a new position in shares of Omega Healthcare Investors in the first quarter valued at $16,446,000. Dimensional Fund Advisors LP boosted its position in shares of Omega Healthcare Investors by 7.9% in the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock valued at $127,831,000 after acquiring an additional 272,299 shares during the period. Finally, Sei Investments Co. boosted its position in shares of Omega Healthcare Investors by 150.8% in the second quarter. Sei Investments Co. now owns 298,761 shares of the real estate investment trust’s stock valued at $10,233,000 after acquiring an additional 179,623 shares during the period. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Price Performance

Omega Healthcare Investors stock opened at $39.74 on Friday. The stock has a market capitalization of $10.73 billion, a price-to-earnings ratio of 29.22, a PEG ratio of 1.28 and a beta of 0.99. Omega Healthcare Investors, Inc. has a 52-week low of $27.53 and a 52-week high of $44.42. The stock’s 50 day moving average price is $40.66 and its two-hundred day moving average price is $36.57. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48.

Omega Healthcare Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Monday, November 4th will be issued a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.74%. The ex-dividend date of this dividend is Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Insider Buying and Selling

In related news, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 36.19 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

OHI has been the subject of a number of recent research reports. Berenberg Bank started coverage on shares of Omega Healthcare Investors in a research report on Friday, October 18th. They issued a “buy” rating and a $45.00 target price for the company. Mizuho downgraded Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and boosted their target price for the stock from $34.00 to $35.00 in a research note on Thursday, July 25th. Royal Bank of Canada upped their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research note on Monday. Truist Financial increased their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. Finally, BMO Capital Markets increased their target price on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research report on Monday, October 7th. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $40.00.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.